Explore more publications!

France Daily Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on France Daily Times.

Press releases published on April 13, 2026

Tribuna.com Présente 15 Fonctionnalités qui Redéfinissent les Possibilités d'une Application Football
PulseForge Achieves Sub-10 µm Silicon Breakthrough in Ultra-Thin Wafer Processing with Photonic Debonding
Hannover House sets ambitious production slate for launch at Cannes Festival
Vol de marchandises : peu d’inquiétudes de la part des gestionnaires de flotte malgré les risques
New SOCIETIES Edition Spotlights AI, Wellness and Design in the Shift Toward Intentional Luxury
ABL Diagnostics Announces Two New Scientific Publications, Reinforcing its Expertise in HIV Sequencing-based Genotyping
ADIFF Presents Transcultural Dialogues Film Series April 24–26, 2026 at Teachers College, Columbia University
Soil Management Market Is Going to Boom – Growth Opportunities Through 2033 | Bayer Crop Science AG, Novozymes
Applications Open for DNDA26 Awards: Celebrating Humanity-Centered Design for Societal Impact and Global Well-Being
Doyield repositionne le débat OTA à l’ère de l’IA dans un podcast de 10 minutes hotels qui bouscule les idées reçues
Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform
Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis
Technip Energies launches its  2026 Employee Share Offering
Technip Energies lance son offre  d'actionnariat salarié 2026
Ministers and Members of Parliament at Paris Blockchain Week 2026: A Historic Signal for the Institutionalization of Crypto-Assets
Facephi Strengthens Its International Expansion with the Opening of a Subsidiary in Canada
Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer
Transgene annonce la fin de la randomisation des patients de la partie Phase 2 de l’essai clinique évaluant TG4050 dans le traitement adjuvant des cancers de la tête et du cou
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
Communiqué de presse : Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions